- Home
- EHC vs COO Comparison
EHC vs COO Comparison
Compare EHC & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHC
- COO
- Stock Information
- Founded
- EHC 1983
- COO 1980
- Country
- EHC United States
- COO United States
- Employees
- EHC N/A
- COO N/A
- Industry
- EHC Hospital/Nursing Management
- COO Ophthalmic Goods
- Sector
- EHC Health Care
- COO Health Care
- Exchange
- EHC Nasdaq
- COO Nasdaq
- Market Cap
- EHC 12.4B
- COO 14.2B
- IPO Year
- EHC 1986
- COO N/A
- Fundamental
- Price
- EHC $118.47
- COO $69.57
- Analyst Decision
- EHC Strong Buy
- COO Buy
- Analyst Count
- EHC 8
- COO 11
- Target Price
- EHC $140.63
- COO $79.27
- AVG Volume (30 Days)
- EHC 637.7K
- COO 2.6M
- Earning Date
- EHC 10-29-2025
- COO 12-04-2025
- Dividend Yield
- EHC 0.60%
- COO N/A
- EPS Growth
- EHC 27.87
- COO 13.33
- EPS
- EHC 5.29
- COO 2.04
- Revenue
- EHC $5,795,600,000.00
- COO $4,045,700,000.00
- Revenue This Year
- EHC $11.57
- COO $6.02
- Revenue Next Year
- EHC $8.79
- COO $5.76
- P/E Ratio
- EHC $23.74
- COO $34.11
- Revenue Growth
- EHC 11.13
- COO 6.35
- 52 Week Low
- EHC $87.85
- COO $61.78
- 52 Week High
- EHC $127.99
- COO $107.84
- Technical
- Relative Strength Index (RSI)
- EHC 33.47
- COO 45.15
- Support Level
- EHC $125.09
- COO $69.37
- Resistance Level
- EHC $127.64
- COO $76.23
- Average True Range (ATR)
- EHC 2.76
- COO 1.91
- MACD
- EHC -0.38
- COO -0.33
- Stochastic Oscillator
- EHC 53.47
- COO 15.38
About EHC Encompass Health Corporation
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
About COO The Cooper Companies Inc.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.